Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Nutrients ; 10(3)2018 Mar 10.
Article in English | MEDLINE | ID: mdl-29534433

ABSTRACT

Offspring of female rats fed either a casein (CAS) diet or a low-isoflavone soy protein isolate (SPI) diet were compared in an animal model of chronic ethanol consumption to investigate whether maternal diet regulates the adaptive responses of offspring to postnatal ethanol exposure and potentially affects the development of liver disease in later life. Female rats were fed either a CAS or an SPI diet before mating, and during pregnancy and lactation. Male offspring from the same litter were pair-fed either a control or ethanol diet for six weeks (CAS/CON, CAS/EtOH, SPI/CON, and SPI/EtOH groups). Serum aminotransferase activities and hepatic inflammatory indicators were higher in the SPI/EtOH group than in the CAS/EtOH group. Ethanol consumption increased serum homocysteine levels, hepatic S-adenosylmethionine:S-adenosylhomocysteine ratio, and hepatic endoplasmic reticulum stress only in offspring of SPI-fed female rats. Total and high-density lipoprotein (HDL) cholesterol levels and mRNA levels of hepatic genes involved in HDL cholesterol assembly were reduced in the SPI group in response to ethanol consumption. In conclusion, offspring of SPI-fed female rats were more susceptible to the later development of alcoholic liver disease than offspring of CAS-fed female rats. Furthermore, maternal SPI consumption altered one-carbon metabolism and cholesterol metabolism of offspring fed an ethanol diet.


Subject(s)
Endoplasmic Reticulum Stress/drug effects , Fatty Liver, Alcoholic/etiology , Lactation , Liver/drug effects , Maternal Nutritional Physiological Phenomena , Prenatal Exposure Delayed Effects , Soybean Proteins/adverse effects , Animals , Bile Acids and Salts/blood , Biomarkers/blood , Dietary Supplements , Dyslipidemias/etiology , Dyslipidemias/pathology , Dyslipidemias/physiopathology , Dyslipidemias/prevention & control , Ethanol/toxicity , Fatty Liver, Alcoholic/pathology , Fatty Liver, Alcoholic/physiopathology , Fatty Liver, Alcoholic/prevention & control , Female , Gene Expression Regulation/drug effects , Genistein/therapeutic use , Liver/pathology , Liver/physiopathology , Male , Organ Size/drug effects , Pregnancy , Protective Agents/therapeutic use , Random Allocation , Rats, Sprague-Dawley
2.
Am J Chin Med ; 44(6): 1207-1220, 2016.
Article in English | MEDLINE | ID: mdl-27627919

ABSTRACT

Alcoholic fatty liver (AFL) is early stage of alcoholic liver disease, which can progress to steatohepatitis, fibrosis, and cirrhosis if alcohol consumption is continued. The pathogenesis of AFL is associated with excessive lipid accumulation in hepatocytes. Resveratrol (RES), a dietary polyphenol found in red wines and grapes, has been shown to have a hepatoprotective effect. Autophagy is a crucial physiological process in cellular catabolism that involves the regulation of lipid droplets. Autophagy maintains a balance between protein synthesis, degradation and self-recycling. In the present study, we evaluated the protective effects of RES (10[Formula: see text]mg/kg, 30[Formula: see text]mg/kg, 100[Formula: see text]mg/kg) on AFL mice fed with an ethanol Lieber-DeCarli liquid diet, and HepG2 cells in the presence of oleic acid and alcohol to investigate whether resveratrol could induce autophagy to attenuate lipid accumulation. The results showed that RES (30[Formula: see text]mg/kg and 100[Formula: see text]mg/kg) treatment significantly attenuated hepatic steatosis and lowered the activities of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride (TG), low density lipoprotein cholesterol (LDL-C). H&E staining showed that RES reduced hepatic lipid accumulation. Transmission electron microscopy (TEM) images showed that RES treatment increased the number of autophagosomes and promoted the formation of autophagy. Western blot analysis showed that RES treatment increased the levels of microtubule-associated protein light chain3- II (LC3-II) and Beclin1, decreased expression of p62 protein. In addition, in vitro studies also demonstrated that RES led to the formation of acidic vesicular organelles (AVOs), however, 3-Methyladenine (3-MA), a specific inhibitor of autophagy, obviously inhibited the above effects of RES. In conclusion, RES has protective effects on alcoholic hepatic steatosis, and the potential mechanism might be involved in inducing autophagy.


Subject(s)
Autophagy/drug effects , Fatty Liver, Alcoholic/drug therapy , Fatty Liver, Alcoholic/physiopathology , Hepatocytes/metabolism , Lipid Droplets/metabolism , Stilbenes/pharmacology , Animals , Autophagy/physiology , Disease Models, Animal , Fatty Liver, Alcoholic/etiology , Fatty Liver, Alcoholic/metabolism , Hep G2 Cells , Humans , Male , Mice, Inbred C57BL , Phytotherapy , Resveratrol , Stilbenes/administration & dosage , Stilbenes/therapeutic use , Vitis , Wine
3.
J Nutr ; 145(12): 2690-8, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26468492

ABSTRACT

BACKGROUND: Zinc deficiency has been well documented in alcoholic liver disease. OBJECTIVE: This study was undertaken to determine whether dietary zinc supplementation provides beneficial effects in treating alcohol-induced gut leakiness and endotoxemia. METHODS: Male Sprague Dawley rats were divided into 3 groups and pair-fed (PF) Lieber-DeCarli liquid diet for 8 wk: 1) control (PF); 2) alcohol-fed (AF; 5.00-5.42% wt:vol ethanol); and 3) AF with zinc supplementation (AF/Zn) at 220 ppm zinc sulfate heptahydrate. The PF and AF/Zn groups were pair-fed with the AF group. Hepatic inflammation and endotoxin signaling were determined by immunofluorescence and quantitative polymerase chain reaction (qPCR). Alterations in intestinal tight junctions and aldehyde dehydrogenases were assessed by qPCR and Western blot analysis. RESULTS: The AF rats had greater macrophage activation and cytokine production (P < 0.05) in the liver compared with the PF rats, whereas the AF/Zn rats showed no significant differences (P > 0.05). Plasma endotoxin concentrations of the AF rats were 136% greater than those of the PF rats, whereas the AF/Zn rats did not differ from the PF rats. Ileal permeability was 255% greater in the AF rats and 19% greater in the AF/Zn rats than in the PF rats. The AF group had reduced intestinal claudin-1, occludin, and zona occludens-1 (ZO-1) expression, and the AF/Zn group had upregulated claudin-1 and ZO-1 expression (P < 0.05) compared with the PF group. The intestinal epithelial expression and activity of aldehyde dehydrogenases were elevated (P < 0.05) in the AF/Zn rats compared with those of the AF rats. Furthermore, the ileal expression and function of hepatocyte nuclear factor 4α, which was impaired in the AF group, was significantly elevated in the AF/Zn group compared with the PF group. CONCLUSIONS: The results demonstrate that attenuating hepatic endotoxin signaling by preserving the intestinal barrier contributes to the protective effect of zinc on alcohol-induced steatohepatitis in rats.


Subject(s)
Dietary Supplements , Endotoxemia/prevention & control , Fatty Liver, Alcoholic/prevention & control , Intestinal Diseases/prevention & control , Zinc/administration & dosage , Aldehyde Dehydrogenase/metabolism , Animals , Claudin-1/analysis , Cytokines/biosynthesis , Endotoxins/analysis , Ethanol/adverse effects , Fatty Liver, Alcoholic/physiopathology , Intestinal Diseases/chemically induced , Intestinal Mucosa/metabolism , Intestines/chemistry , Intestines/enzymology , Liver/pathology , Liver/physiopathology , Macrophage Activation , Male , Occludin/analysis , Permeability/drug effects , Rats , Rats, Sprague-Dawley , Tight Junction Proteins/analysis , Zinc/deficiency , Zonula Occludens-1 Protein/analysis
4.
Mitochondrion ; 15: 40-51, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24727595

ABSTRACT

Exercise is considered a non-pharmacological tool against several lifestyle disorders in which mitochondrial dysfunction is involved. The present study aimed to analyze the preventive (voluntary physical activity-VPA) and therapeutic (endurance training-ET) role of exercise against non-alcoholic steatohepatitis (NASH)-induced liver mitochondrial dysfunction. Sixty male Sprague-Dawley rats were divided into standard-diet sedentary (SS, n=20), standard-diet VPA (SVPA, n=10), high-fat diet sedentary (HS, n=20) and high-fat diet VPA (HVPA, n=10). After 9weeks of diet-treatment, half of SS and HS animals were engaged in an ET program (SET and HET) for 8weeks, 5days/week and 60min/day. Liver mitochondrial oxygen consumption and transmembrane-electric potential (ΔΨ) were evaluated in the presence of glutamate-malate (G/M), palmitoyl-malate (P/M) and succinate (S/R). Mitochondrial enzymes activity, lipid and protein oxidation, oxidative phosphorylation (OXPHOS) subunits, cytochrome c, adenine nucleotide translocator (ANT) and uncoupling protein-2 (UCP2) content were assessed. HS groups show the histological features of NASH in parallel with decreased ΔΨ and respiratory control (RCR) and ADP/O ratios (G/M and P/M). A state 3 decrease (G/M and S/R), FCCP-induced uncoupling respiration (S/R) and ANT content were also observed. Both exercise types counteracted oxygen consumption (RCR, ADP/O and FCCP-uncoupling state) impairments and improved ΔΨ (lag-phase). In conclusion, exercise prevented or reverted (VPA and ET, respectively) the bioenergetic impairment induced by NASH, but only ET positively remodeled NASH-induced liver structural damage and abnormal mitochondria. It is possible that alterations in inner membrane integrity and fatty acid oxidation may be related to the observed phenotypes induced by exercise.


Subject(s)
Energy Metabolism , Fatty Liver, Alcoholic/physiopathology , Liver/pathology , Liver/physiopathology , Mitochondria/pathology , Mitochondria/physiology , Physical Conditioning, Animal , Animals , Disease Models, Animal , Fatty Liver, Alcoholic/therapy , Mitochondria/ultrastructure , Rats, Sprague-Dawley
5.
Int J Food Sci Nutr ; 65(4): 482-8, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24392995

ABSTRACT

In the present study, the curative effects of crude polysaccharides (PSs) from mushrooms on the symptoms of alcoholic liver injury were investigated. PSs from Agaricus bisporus, Agaricus brasiliensis, and Phellinus linteus fruiting bodies were administered by gavage at levels of 100 mg per kg body weight per day for 7 d after the onset of the disease. The caspase-3 activity, mitochondrial membrane potential, mitochondrial outer membrane integrity of the liver tissues of sacrificed rats, and the serum alanine aminotransferase (ALT) levels were determined. In addition, light and transmission electron microscope (TEM) studies were performed for histopathological and cytological evaluations on liver sections. PSs from A. brasiliensis decreased ALT level and mitochondrial membrane potential and increased the outer membrane integrity; microscopic examinations also revealed normal hepatocytes and tissue. On the basis of our data, it can be argued that crude PSs from Agaricus brasiliensis have therapeutic potential for alcoholic liver injury.


Subject(s)
Agaricus/chemistry , Basidiomycota/chemistry , Drug Discovery , Fatty Liver, Alcoholic/drug therapy , Fruiting Bodies, Fungal/chemistry , Fungal Polysaccharides/therapeutic use , Liver/drug effects , Animals , Caspase 3/metabolism , Ethnopharmacology , Fatty Liver, Alcoholic/metabolism , Fatty Liver, Alcoholic/pathology , Fatty Liver, Alcoholic/physiopathology , Fungal Polysaccharides/isolation & purification , Liver/metabolism , Liver/physiopathology , Liver/ultrastructure , Male , Medicine, Traditional , Membrane Potential, Mitochondrial/drug effects , Microscopy, Electron, Transmission , Mitochondrial Membranes/drug effects , Mitochondrial Membranes/metabolism , Neutrophil Infiltration/drug effects , Random Allocation , Rats, Sprague-Dawley
6.
Wien Med Wochenschr ; 164(1-2): 3-8, 2014 Jan.
Article in German | MEDLINE | ID: mdl-23842647

ABSTRACT

Severe alcoholic hepatitis is still associated with high mortality and presence of liver failure manifested by jaundice, coagulopathy and encephalopathy is a poor prognostic indicator. The management of these patients includes at first hand several supportive measures as treatment of alcohol withdrawal, administration of fluid and vitamins and admission to an intensive care unit in the unstable patient. Glucocorticoids have been since decades the most intensively studied therapy in alcoholic hepatitis and are effective in certain subgroups. Indication for such a therapy is usually defined on a Maddrey Discriminant Function > 32. The Lille score at day 7 is used to decide whether corticosteroid therapy should be stopped or continued for a 1 month course. Nutritional supplementation is also likely to be beneficial. The main progress in better understanding its pathophysiology has come from cytokine studies. Various proinflammatory cytokines such as tumor necrosis factor-alpha (TNFα) or interleukin-1 (IL-1) have been proposed to play a role in this disease. This advancement has recently led to pilot studies investigating anti-TNF drugs such as pentoxifylline, infliximab (anti-TNF antibody) or etanercept in the treatment of this disease. These studies revealed besides for pentoxifylline rather negative results. Despite this fact, targeting of certain cytokines such as IL-1 remains an attractive treatment concept for this devastating disorder in the future.


Subject(s)
Hepatitis, Alcoholic/rehabilitation , Alcoholism/physiopathology , Alcoholism/rehabilitation , Antibodies, Monoclonal/administration & dosage , Combined Modality Therapy , Etanercept , Fatty Liver, Alcoholic/diagnosis , Fatty Liver, Alcoholic/physiopathology , Fatty Liver, Alcoholic/rehabilitation , Fluid Therapy , Glucocorticoids/administration & dosage , Hepatitis, Alcoholic/diagnosis , Hepatitis, Alcoholic/physiopathology , Humans , Immunoglobulin G/administration & dosage , Infliximab , Intensive Care Units , Interleukin-1/blood , Liver Failure, Acute/diagnosis , Liver Failure, Acute/physiopathology , Liver Failure, Acute/rehabilitation , Liver Function Tests , Liver Transplantation , Patient Selection , Pentoxifylline/administration & dosage , Pilot Projects , Prognosis , Receptors, Tumor Necrosis Factor/administration & dosage , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/blood , Vitamins/administration & dosage
7.
Br J Nutr ; 108(7): 1256-63, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22289614

ABSTRACT

Sida cordifolia Linn. (Malvaceae) is a plant used in folk medicine for the treatment of the inflammation of oral mucosa, asthmatic bronchitis, nasal congestion and rheumatism. We studied the hepatoprotective activity of 50 % ethanolic extract of S. cordifolia Linn. against alcohol intoxication. The duration of the experiment was 90 d. The substantially elevated levels of toxicity markers such as alanine aminotransferase, aspartate aminotransferase and γ-glutamyl transferase due to the alcohol treatment were significantly lowered in the extract-treated groups. The activity of antioxidant enzymes and glutathione content, which was lowered due to alcohol toxicity, was increased to a near-normal level in the co-administered group. Lipid peroxidation products, protein carbonyls, total collagen and hydroxyproline, which were increased in the alcohol-treated group, were reduced in the co-administered group. The mRNA levels of cytochrome P450 2E1, NF-κB, TNF-α and transforming growth factor-ß1 were found to be increased in the alcohol-treated rats, and their expressions were found to be decreased in the co-administered group. These observations were reinforced by histopathological analysis. Thus, the present study clearly indicates that 50 % ethanolic extract of the roots of S. cordifolia Linn. has a potent hepatoprotective action against alcohol-induced toxicity, which was mediated by lowering oxidative stress and by down-regulating the transcription factors.


Subject(s)
Antioxidants/therapeutic use , Dietary Supplements , Fatty Liver, Alcoholic/prevention & control , Hepatic Insufficiency/prevention & control , Malvaceae/chemistry , Plant Extracts/therapeutic use , Plant Roots/chemistry , Animals , Antioxidants/isolation & purification , Biomarkers/metabolism , Cytochrome P-450 CYP2E1/genetics , Cytochrome P-450 CYP2E1/metabolism , Cytokines/genetics , Cytokines/metabolism , Down-Regulation , Ethanol/chemistry , Fatty Liver, Alcoholic/metabolism , Fatty Liver, Alcoholic/pathology , Fatty Liver, Alcoholic/physiopathology , Hepatic Insufficiency/etiology , Lipid Peroxidation , Liver/metabolism , Liver/pathology , Liver/physiopathology , Male , Medicine, Ayurvedic , Oxidative Stress , Plant Extracts/isolation & purification , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Solvents/chemistry
8.
Eksp Klin Gastroenterol ; (6): 113-9, 2011.
Article in Russian | MEDLINE | ID: mdl-22168090

ABSTRACT

The aim of this study was a comparative evaluation of the effectiveness of hepatoprotectors (Metadoksin and Silybin) in the complex treatment of patients with alcoholic liver disease. The article presents data on the use of Metadoksin and Silybin in the treatment of alcohol steatohepatitis and liver cirrhosis alcoholic etiology of the total number of comparison groups 66 patients formed on the basis of 642 patients treated with alcoholic liver disease. Was studied dynamics of blood biochemical parameters during therapy, as well as the severity of clinical syndrome (pain, dyspeptic, asthenic) before and after treatment. Higher Metadoksin efficacy in comparison with Silybin explained by antidepressiv effect of the drug. The effect of restoration of damaged toxic effect of alcohol liver tissue as a result of Metadoksin impact was proved in the experimental part of the study, an experiment on rats.


Subject(s)
Antioxidants/administration & dosage , Fatty Liver, Alcoholic/drug therapy , Liver Cirrhosis, Alcoholic/drug therapy , Silymarin/administration & dosage , Adult , Aged , Animals , Antioxidants/adverse effects , Fatty Liver, Alcoholic/blood , Fatty Liver, Alcoholic/physiopathology , Female , Humans , Liver Cirrhosis, Alcoholic/blood , Liver Cirrhosis, Alcoholic/physiopathology , Liver Cirrhosis, Experimental/blood , Liver Cirrhosis, Experimental/drug therapy , Liver Cirrhosis, Experimental/physiopathology , Male , Middle Aged , Rats , Silybin , Silymarin/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL